Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 5/2016

01-04-2016 | Letter to the Editor

Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review

Authors: Chi-Ching Chen, Chieh-Lin Teng, Su-Peng Yeh

Published in: Annals of Hematology | Issue 5/2016

Login to get access

Excerpt

Dear Editor, …
Literature
1.
von den Driesch P, Staib G, Simon M Jr, Sterry W (1997) Subcutaneous T-cell lymphoma. J Am Acad Dermatol 36:285–289CrossRefPubMed
2.
Al Zolibani AA, Al Fawzan S, Al Robaee AA, Qureshi MG, Nosian HA (2006) Subcutaneous panniculitis‐like T‐cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A. SKINmed Dermatol Clin 5:195–197CrossRef
3.
Tsukamoto Y, Yoshioka K, Omura Y et al (2006) Subcutaneous panniculitislike T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A. Intern Med 45:21–24CrossRefPubMed
4.
Rojnuckarin P, Nakorn TN, Assanasen T, Wannakrairot P, Intragumtornchai T (2007) Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma 48:560–563CrossRefPubMed
5.
Chen R, Liu L, Liang YM (2010) Treatment relapsed subcutaneous panniculitis-like T-cell lymphoma together HPS by cyclosporin A. Hematol Rep 2. doi:10.​4081/​hr.​2010.​e9
6.
Jung HR, Yun SY, Choi JH, Bae SH, Ryoo H-M, Kum Y-S (2011) Cyclosporine in relapsed subcutaneous panniculitis-like T-cell lymphoma after autologous hematopoietic stem cell transplantation. Cancer Res Treat 43:255CrossRefPubMedPubMedCentral
7.
Mizutani S, Kuroda J, Shimura Y et al (2011) Cyclosporine A for chemotherapy-resistant subcutaneous panniculitis-like T cell lymphoma with hemophagocytic syndrome. Acta Haematol 126:8–12CrossRefPubMed
8.
Go S-I, Lee WS, Kang MH, Kim I-S, Kim DC, Lee J-H (2012) Cyclosporine A treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: a case with long-term follow-up. Korean J Hematol 47:146–149CrossRefPubMedPubMedCentral
9.
10.
Lee WS, Hwang J-H, Kim MJ et al (2014) Cyclosporine A as a primary treatment for panniculitis-like T cell lymphoma: a case with a long-term remission. Cancer Res Treat 46:312CrossRefPubMedPubMedCentral
Metadata
Title
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review
Authors
Chi-Ching Chen
Chieh-Lin Teng
Su-Peng Yeh
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 5/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2615-0

Other articles of this Issue 5/2016

Annals of Hematology 5/2016 Go to the issue

Original Article

A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients

Review Article

Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients

Original Article

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era

Letter to the Editor

A Japanese pedigree with a p.A95V mutation in the MYH9 gene demonstrates inherited macrothrombocytopenia without Alport manifestations

Letter to the Editor

A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms

Review Article

Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits